Towa Pharmaceutical Co., Ltd. Announces Earnings Results for the Second Quarter of Fiscal Year 2016; Provides Earnings Guidance for the Full Year Ending March 2016; Revises Capital Expenditure Guidance for the Year Endings March 2017 and 2018
May 14, 2016 at 06:45 am IST
Share
Towa Pharmaceutical Co., Ltd. announced earnings results for the second quarter of fiscal year 2016. For the period, the company reported net sales of JPY 39,162 million compared to JPY 33,468 million a year ago. Operating income was JPY 5,522 million compared to JPY 4,183 million a year ago. Ordinary income was JPY 5,613 million compared to JPY 5,550 million a year ago. Profit attributable to owners of parent was JPY 4,014 million compared to JPY 4,068 million a year ago.
The company provided earnings guidance for the full year ending March 2016. For the period, the company expects net sales of JPY 82,000 million, operating income of JPY 11,500 million, ordinary income of JPY 11,500 million and profit attributable to owners of parent of JPY 8,200 million. The company revised capital expenditure guidance of JPY 18,100 million against previous guidance of JPY 13,600 million
For the year ending March 2017, the company revised capital expenditure guidance of JPY 20,700 million against previous guidance of JPY 17,000 million.
For the year ending March 2018, the company revised capital expenditure guidance of JPY 39,000 million against previous guidance of JPY 20,000 million.
Towa Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The main products are generic drugs, which are launched after the efficacy and safety of new drugs have been confirmed for a certain period of time. It is a drug with the same effect, usage and dosage. The Company is involved in the sale and outsourced manufacture of products and generic drugs. The Company is involved in the research and outsourced manufacture of active pharmaceutical ingredient and soft capsules. The Company is also involved in the planning, development, contract manufacturing of health foods, general foods, miscellaneous goods and others.
Towa Pharmaceutical Co., Ltd. Announces Earnings Results for the Second Quarter of Fiscal Year 2016; Provides Earnings Guidance for the Full Year Ending March 2016; Revises Capital Expenditure Guidance for the Year Endings March 2017 and 2018